| Dr Monica Arora, MD | |
|
6829 N 72nd St Ste 4300, Omaha, NE 68122-1727 | |
| (402) 572-3900 | |
| (402) 572-3375 |
| Full Name | Dr Monica Arora |
|---|---|
| Gender | Female |
| Speciality | Psychiatry & Neurology - Psychiatry |
| Location | 6829 N 72nd St Ste 4300, Omaha, Nebraska |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225142375 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 21861 (Nebraska) | Primary |
| Entity Name | Alegent Creighton Health |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033288923 PECOS PAC ID: 1850285255 Enrollment ID: O20040326000802 |
News Archive
Mitsubishi Chemical Medience Corporation announced today that the U.S. Food and Drug Administration (FDA) has granted 510(k) premarketing notification clearance to the PATHFAST cTnI-II diagnostic test, clearing the way for its sale in the United States.
Biomedical researchers often confront large quantities of information that may be amassed in many forms: vital signs, blood cell counts, lengthy DNA sequences, bar graphs, MRIs, patient demographics, and so much more. How do researchers assemble, access and analyze all that data without having to become specialized database technicians themselves?
Results from a new multi-year initiative provide further evidence that a school prevention program called Botvin LifeSkills Training (LST) can dramatically cut teen cigarette smoking. After identifying LST as the top-rated prevention program, researchers in Italy translated the LST program into Italian and adapted it for Italian youth.
iCAD, Inc., an industry-leading provider of advanced image analysis, workflow solutions and radiation therapies for the early identification and treatment of cancer, announces its featured products at the European Society of Radiology's annual meeting being held in Vienna, Austria from March 3 - 7, 2011.
Regeneron Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration has approved EYLEA (aflibercept) Injection, known in the scientific literature as VEGF Trap-Eye, for the treatment of patients with neovascular (wet) Age-related Macular Degeneration (AMD) at a recommended dose of 2 milligrams every four weeks for the first 12 weeks, followed by 2 mg every eight weeks.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Monica Arora, MD 7261 Mercy Rd, Omaha, NE 68124-2311 Ph: (402) 398-6248 | Dr Monica Arora, MD 6829 N 72nd St Ste 4300, Omaha, NE 68122-1727 Ph: (402) 572-3900 |
News Archive
Mitsubishi Chemical Medience Corporation announced today that the U.S. Food and Drug Administration (FDA) has granted 510(k) premarketing notification clearance to the PATHFAST cTnI-II diagnostic test, clearing the way for its sale in the United States.
Biomedical researchers often confront large quantities of information that may be amassed in many forms: vital signs, blood cell counts, lengthy DNA sequences, bar graphs, MRIs, patient demographics, and so much more. How do researchers assemble, access and analyze all that data without having to become specialized database technicians themselves?
Results from a new multi-year initiative provide further evidence that a school prevention program called Botvin LifeSkills Training (LST) can dramatically cut teen cigarette smoking. After identifying LST as the top-rated prevention program, researchers in Italy translated the LST program into Italian and adapted it for Italian youth.
iCAD, Inc., an industry-leading provider of advanced image analysis, workflow solutions and radiation therapies for the early identification and treatment of cancer, announces its featured products at the European Society of Radiology's annual meeting being held in Vienna, Austria from March 3 - 7, 2011.
Regeneron Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration has approved EYLEA (aflibercept) Injection, known in the scientific literature as VEGF Trap-Eye, for the treatment of patients with neovascular (wet) Age-related Macular Degeneration (AMD) at a recommended dose of 2 milligrams every four weeks for the first 12 weeks, followed by 2 mg every eight weeks.
› Verified 3 days ago
Dr. David Berman Walker, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 10625 Calhoun Rd, Omaha, NE 68112 Phone: 402-457-1300 Fax: 402-457-1403 | |
Dr. Srinivas Dannaram, M.D Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: Creighton Nebraska, Department Of Psychiatry 985582, Omaha, NE 68198 Phone: 402-552-6244 | |
Albert Matthew Dickan, Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 7710 Mercy Rd Ste 202, Omaha, NE 68124 Phone: 402-280-4195 | |
Nicole J Bergerson, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 9239 W Center Rd, Suite 225, Omaha, NE 68124 Phone: 402-505-9550 Fax: 402-614-3414 | |
Ho Taik Sung, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 7710 Mercy Road, Suite 202, Cu Department Of Psychiatry, Omaha, NE 68124 Phone: 402-280-4195 | |
Michael L Meyer, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 9239 West Center Rd, Suite 205, Omaha, NE 68124 Phone: 402-354-8080 Fax: 402-354-8044 | |
Dr. Frederick Petty, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 4101 Woolworth Ave, 116a, Omaha, NE 68105 Phone: 402-346-8800 Fax: 402-449-0677 |